Dr. Henrich’s laboratory/research group specializes in immunmodulatory, cytoreductive chemotherapeutic, and stem cell transplantation approaches to HIV-1 cure.
They are also involved in designing and implementing novel nano/microtechnologies and PET-based imaging approaches to characterize viral reservoirs.
Most recently, Dr. Henrich studied the long-term inflammatory and immunological sequalae of SARS-CoV-2 infection and human herpes virus reactivation during acute viral infections.
